Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...
Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.
Patients taking apixaban had a similar risk of major and minor bleeding events as those receiving standard of care therapy. SAN DIEGO—Apixaban therapy resulted in a low risk of venous thromboembolism ...